International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)

The summary for the International Research in Infectious Diseases (R01 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

International Research in Infectious Diseases (R01 Clinical Trial Not Allowed): The purpose of this Funding Opportunity Announcement (FOA) is to support applications for high-priority, regionally relevant infectious diseases research by international investigators in resource-constrained countries. Applicant organizations must be headquartered in foreign (non-U.S.) resource-constrained countries (i.e. low-income economies, lower-middle-income economies, and upper-middle-income economies by World Bank Classification). Applicant organizations headquartered in low- and lower-middle income economy countries are particularly encouraged to apply. Eligibility status of applicant organizations will be determined by the World Bank Classification list at the time of application submission.

Federal Grant Title:	International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AI-23-023
Type of Funding:	Grant
CFDA Numbers:	93.855
CFDA Descriptions:	Information not provided
Current Application Deadline:	August 1st, 2025
Original Application Deadline:	August 1st, 2025
Posted Date:	April 14th, 2023
Creation Date:	April 14th, 2023
Archive Date:	September 6th, 2025
Total Program Funding:
Maximum Federal Grant Award:	$125,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	April 14th, 2023

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-23-023.html
Grant Announcement Contact: NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • Advancing Translation of Long-Acting Strategies for HIV and HIV-Associated Co-infections (...; • Combating Antibiotic-Resistant Bacteria Interdisciplinary Units (CARBIRUs) (P01 Clinical T...; • Centers for Accelerating Phage (Bacteriophage) Therapy to Combat ESKAPE Pathogens (CAPT-CE...; • New Therapeutic Strategies for Genital Herpes (R21/R33 Clinical Trial Not Allowed); • Development of Alternative Human Models of Radiation-Induced Injuries (Extracorporeal Syst...; • Center for HIV/AIDS Vaccine Immunology (CHAVI); • Genomics of Transplantation Cooperative Research Program; • Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health: • Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required); • Alcohol Health Services Research (R01 Clinical Trial Optional); • Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required); • Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Re...; • Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the...